The impact of chronic cough: a cross-sectional European survey by Chamberlain, SAF et al.
1 
 
The impact of Chronic cough: a cross sectional European survey. 
Authors: Chamberlain, SAF1,2.,Garrod, R3., Douiri, A 4, 5., Masefield, S6., Powell, 
P6.,Bücher, C2., Pandyan A2., Morice, A.H7, Birring, S.S1.   
1Division of Asthma, Allergy and Lung Biology, King’s College London, London, 
United Kingdom;2School of Health and Rehabilitation, Keele University, Keele, 
United Kingdom.3 Denmark Hill Campus, King’s College London, United Kingdom; 
4Department of Primary Care and Public Health Sciences,  King’s College London, 
United Kingdom; 5NIHR Biomedical Centre, King’s College London, United Kingdom; 
6 European Lung Foundation, Sheffield, United Kingdom; 7Hull York Medical School, 
Castle Hill Hospital, Cottingham, United Kingdom. 
 
Corresponding Author: Dr Surinder S Birring, Division of Asthma, Allergy and Lung 
Biology, Denmark Hill campus, King’s College London, Denmark Hill, London, SE5 
9RS, United Kingdom. Telephone: (+44) 203 299 4630. Email: 
surinder.birring@nhs.net 
 
Contributions: Conception and design: SSB, AM, SM, PP, RG; Acquisition of data: 
SSB, SM, PP; Analysis and interpretation: SC, SSB, AD, CB, AP; Drafting of the 
manuscript for important intellectual content: SC, SSB, RG; Revision of manuscript: 
SC, SSB, RG, SM, PP, AM, AD, CB, AP.  
 
Manuscript word count: 2569 
 
 
 
 
 
 
2 
 
Introduction 
The prevalence of chronic cough has been estimated as affecting 11-13% of the 
population.[1-4] Chronic cough is associated with significant physical and 
psychological morbidity.[5, 6] Adverse physical symptoms associated with cough 
include syncope, incontinence, chest pain, headaches and sore throat. Depression, 
anxiety and social embarrassment are also common.[5, 7, 8] The impact of chronic 
cough has largely been investigated in patients attending specialist cough clinics [5, 
6, 9]. Few studies have investigated the impact of chronic cough in patients based in 
the community. The aim of this study, in collaboration with the European Lung 
Foundation (ELF), was to investigate the impact of chronic cough from the patients’ 
perspective in a wide range of European countries. An internet based survey was 
developed to investigate the impact, medical consultations, diagnoses, treatments 
and needs of patients with chronic cough. 
Methods 
Subjects 
Adults with chronic cough (duration > 8 weeks) of any cause were recruited using an 
internet-based survey. Exclusion criteria were: acute and sub-acute cough, age <18 
years and non-European country of residence. A patient information sheet was 
provided online on the ELF website. Participants who selected to complete the online 
survey were considered to have given implied consent. Secondary anonymised data 
from the survey was analysed.  
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Survey Development 
Phase 1 – Item generation 
A preliminary survey (21 items) was developed following a review of the chronic 
cough health related quality-of-life (QoL) literature and published surveys of chronic 
cough. The survey was also reviewed and discussed within the European 
Respiratory Society (ERS) Chronic cough Taskforce (15 respiratory physicians from 
nine countries), a multidisciplinary team (respiratory physician and physiotherapists, 
Kings College Hospital) and the ELF. The survey contained both open-ended and 
closed questions with response scales. 
Phase 2 – Survey refinement 
The survey was adapted for use on the internet and reduced to 17 items in response 
to feedback received during the item generation phase. The items were grouped into 
five categories: “About your cough,” “How are you affected by your cough?” 
“Diagnosis of your cough,” “Treatment of your cough” and “Support for patients with 
cough” (Appendix A). 
Phase 3 – Translation of survey 
The survey was translated by Web-Translations (Leeds, UK). Forward-back 
translation methodology was used by native speakers to ensure accuracy. The back 
translated survey was checked by the original author (SSB) for accuracy and 
differences were reconciled during a harmonisation process. The survey was 
translated into 12 languages: English, German, French, Spanish, Greek, Romanian, 
Lithuanian, Swedish, Italian, Bulgarian, Polish and Russian.  
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Internet survey 
The survey was launched by the ELF on their website www.european-lung-
foundation.org (website has now changed to www.europeanlung.org) using a Survey 
Monkey survey package. Google AdWords was used to advertise the survey on 
Google searches. This used keywords or search terms entered into a Google search 
website to return the cough survey in the Google results page and advertisement 
sidebar. The keywords set for this survey were “chronic cough,” “cough survey,” “a 
cough that won’t go away” and “can lung disease make you cough”. These key 
words were identified by the ELF, following review of the literature and online 
resources for cough. Keywords were translated and applied for each survey 
language. The survey was promoted by the ELF by developing advertisement 
posters in all survey languages with dissemination to all ERS members (>10,000) 
and ELF patient organisation network (>160 organisations). The posters were 
available on the ELF website to download. The survey was also promoted in the ELF 
monthly newsletter and via social media (Twitter and Facebook). 
Analysis 
Count data were expressed as frequencies and percentages of the total number of 
participants responding to each question. The data were analysed as a whole 
sample and then as sub-groups according to country of residence (countries with 
>50 responders) and gender. Categorical data for “the impact of cough” questions 
(questions 5-8, appendix A) were summarised as binary variables to enable 
calculation of the proportions of participants with the symptom. Open questions 
(questions 2, 16, 19 and 20; Appendix A) were analysed by frequency content 
analysis. Preliminary categories were further refined to generate consolidated 
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themes. The data generated by questions relating to further information and support 
were merged for analysis (questions 19 and 20). 
Results 
The survey was available between January 2012 and April 2013. 1,968 participants 
responded and completed the survey; 1,120 met the inclusion criteria. The reasons 
for excluding participants are stated in Figure 1.  
Figure 1.Flowchart of survey responses and exclusions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data presented as number of survey responses.  
 
  519 responses excluded as   
acute cough 
 
1968 survey responses 
1449 survey responses 
  54 responses excluded as   
             Age <18 
 
  52 responses excluded as   
             Non-European 
 
1395 survey responses 
1343 survey responses 
1120 survey analysed 
 223 responses excluded as   
no cough questions answered 
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Sixty-seven percent of respondents were female, the mean age of respondents was 
51 years (SD 15, range 18-87) and 83% were non-smokers (participant 
demographics are presented in Table 1).  
Table 1: Respondents Demographics 
Subjects (n) 1120 
Age (years)           All 
                             Male 
                             Female 
  51  
  51  
  51 
(15) 
(17) 
(14) 
 
Female n (%) 
 
489  
 
(67) 
   
Ethnicity n (%)     
   White Caucasian 540 (90) 
   Black Caribbean     3 (0.5) 
   Black African     3 (0.5) 
   East Asian e.g. Japan, China     3 (0.5) 
   South Asian e.g. India,  
   Bangladesh 
    4 (0.7) 
   Mixed     5 (0.8) 
   Other   42 (7) 
   
Current smokers n (%) 185 (17) 
   
Seen a doctor regarding cough at least once n (%) 1043 
 
(93) 
Seen a doctor regarding cough ≥3 times n (%) 807 (72) 
 
Attended specialist cough clinic (%) 135 (13) 
Data presented as mean (standard deviation) unless otherwise stated 
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The respondents resided in 29 European countries (Figure 2). The countries with the 
five highest response rates were United Kingdom (UK) (n=136, 20%), Germany 
(n=114, 18%), France (n= 76, 11%), Italy (n= 70, 10%) and Poland (n= 67, 10%). 
 
Diagnosis 
Median duration of cough was between 2-5 years. There were two peaks of cough 
duration; twenty-two percent, reported an early chronic cough (3-6month duration) 
and a similar number, twenty percent reported a cough duration of 10 or more years 
(Figure 3).  
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Figure 3. Cough Duration of Survey Respondents.  
 
 
Data presented as percentage of survey respondents. 
 
Fifty-three percent (n=562) of respondents reported they had been given a diagnosis 
for their cough (Figure 4). Seven percent of respondents who had been given a 
diagnosis had been given two or more diagnoses. Asthma was the most common 
diagnosis reported (23%; Figure 4). 
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Figure 4. Cough Diagnoses of Survey Respondents.  
 
 
 
Data presented as number of survey respondents. GORD – Gastro-oesophageal 
reflux; PND – Post-nasal drip; COPD – Chronic Obstructive Respiratory Disease; 
ACE-I – Angiotensin-converting-enzyme Inhibitor; ILD – Interstitial Lung Disease; 
Other – includes non-disclosed diagnoses of cough; PCD – Primary Cillary 
dyskinesia. First, second and third diagnoses were defined as the first, second and 
third diagnoses listed by survey respondents in response to Survey Question 10. 
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Impact of chronic cough 
Ninety-six percent (n=1,055) of responders reported that their cough affected their 
QoL. Eighty-one percent (n=890) reported that their cough affected the activities they 
liked to do. Ninety-one percent (n=1,000) reported feeling fed-up and depressed 
because of their cough and 94% (n=1,030) reported that their cough disturbed or 
worried their family and friends. The impact of cough was consistent across the top 
five countries of residence for the respondents (Table 2). 
Table 2: Impact of chronic cough (top five response countries). 
Data presented as % of responders (95% Confidence Intervals) 
There were significant gender differences in the limitation of activities due to cough; 
a significantly higher proportion of women (87%; Confidence Interval (CI) 84-90%) 
than men (77%; 95 CI 72-82%) reported limitations (difference in proportion 10%; CI 
4-16%). More women (94%; CI 92-96%) than men (90%; CI 85-93%) reported 
feeling fed up or depressed due to their cough (difference in proportion 5%; 95 CI 0-
9%). No significant differences in population proportions were found between gender 
for impact on QoL or on family and friends. 
 
Country Negative 
Impact on 
activities  
Feeling fed 
up or 
depressed 
Negative 
Impact on 
quality of life 
Worrying or 
disturbing family 
or friends 
UK 87 (80-91) 94 (89-97) 96 (91-98) 98 (94-99) 
Germany 85 (77-90) 98 (94-100) 98 (94-100) 90 (83-94) 
France 75 (64-83) 92 (84-96) 97 (91-99) 95 (87-98) 
Italy 74 (63-83) 90 (81-95) 96 (88-99) 94 (86-98) 
Poland 90 (80-95) 90 (80-95) 97 (90-99) 99 (92-100) 
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Management and treatment of chronic cough 
The majority of respondents had seen a doctor about their cough (Table 1). Seventy-
two percent of participants had seen a doctor ≥3 times in relation to their cough. 
Thirteen percent reported that they had attended a specialist cough clinic.  Only 30% 
of respondents felt their doctor had dealt with their cough thoroughly. Participants 
were asked in an open-ended question why they had first consulted their doctor. This 
question generated seven themes: the characteristics of the cough (n=422), physical 
symptoms associated with cough (n=380), possible viral infection symptoms 
(n=140), psychological symptoms associated with cough (n=88), to consult a doctor 
about existing respiratory or other health condition (n=80), social symptoms 
associated with cough (n=76) and for diagnosis/assessment and treatment for the 
cough (n=31), (Online Appendix B). Some examples of quotations from respondents 
are listed in Online Appendix C. 
Most respondents reported limited (57%) or no (36%) effectiveness of medications 
they had tried for cough. Only 7% reported that medications they had tried for their 
cough were effective. Medications found helpful for their cough were reported by 222 
responders (Question 16 – open ended question; see Table 3).  Sixty-nine percent of 
respondents reported over-the-counter medications were not effective. 
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Table 31: Effective medications for cough reported by respondents 
 
Medication % 
Corticosteroids  (oral and inhaled) 37 
Antibiotics 23 
Bronchodilators 21 
Over the counter cough medications 17 
Gastroesophageal Reflux medications  
(proton-pump inhibitor (PPI), non-PPI and unspecified reflux 
medications) 
10 
Antihistamine/anti-allergy medications 7 
Opiates 6 
Mucolytics (tablets and nebulised) 6 
Unspecified asthma treatment 4 
Nasal sprays (decongestant and corticosteroids) 4 
Homeopathy/herbal medications 4 
Leukotriene antagonists 3 
Amitriptyline    0.5 
Bronchovaxon (immunostimulant, Bacterial Lysate)    0.5 
NSAID    0.5 
Gabapentin    0.5 
  
Other  1 
Data presented as percentage of the number of respondents who reported 1 or more 
effective medications.  73% of respondents listed one medication only, 19% listed two 
medications and 8% listed ≥ 3 medications.  
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Information and support 
Eighty-eight percent of respondents reported that they would like more information 
on chronic cough to be available and 78% reported that they would like to receive 
more information about the ERS/ELF Chronic cough Task Force. The open-ended 
questions concerning further information and support needs of the respondents 
generated 20 themes (Table 4). The two most common themes were the need for 
further patient information relating to the treatment and on causes of cough. 
Examples of quotations from respondents requesting further information and support 
are listed in Online Appendix D. 
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Table 4: Information requested by respondents: a qualitative analysis 
 
Themes N 
(Total = 991) 
Treatment 308 
Causes 127 
Self-help and alternative therapies  103 
General information in a variety of formats  95 
Better understanding, awareness and support from doctors  74 
Assessment 68 
Information on access to specialist cough clinics  65 
Where to get help  33 
Information on cough related symptoms  20 
Further research and sharing of knowledge between specialists  19 
Cough prevention  18 
Better public awareness of chronic cough  17 
Being able to liaise with other people who suffer with chronic cough  13 
Psychological support  11 
Information on triggers for cough  6 
Why chronic cough reoccurs 4 
Information on how to stop smoking  4 
Information on prognosis and long term effects of chronic cough  2 
Information on types of chronic cough 2 
Definition of chronic cough  2 
Data presented as number of responses (n) for each theme. 
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Discussion 
This community-based survey investigated the impact of chronic cough in a large 
number of participants living in 29 European countries.   The demographics of 
respondents to this survey were consistent with previous studies of chronic cough 
that report a middle aged, female predominance.[10-13] There was an adverse 
impact of cough on health-related QoL in most respondents, which was consistent 
across the top five response countries.  The impact on activities was more significant 
in females compared to males.   Most participants reported that their doctor had not 
‘dealt with their cough thoroughly’ and that medications were largely ineffective. 
This survey has highlighted the significant adverse impact of chronic cough to the 
individual.  The respondents had consulted their physician for a wide range of 
reasons, such as the severity of cough, adverse physical and psychological 
symptoms associated with cough and the social impact.   The effect on health-
related QoL was consistent with previous studies conducted in specialist Cough 
Clinics by French et al[9] and Birring et al.[6]  In contrast to French et al[14], a 
gender difference was not found in the impact on health-related QoL. This may be 
because we did not use validated questionnaires such as the cough-specific QoL 
questionnaire (CQLQ)[15] and the Leicester cough questionnaire (LCQ)[6] to assess 
health-related QoL. Most respondents also reported feeling ‘fed up or depressed’ 
because of their cough.   This finding is consistent with those of Dicipingaitis et al[8] 
and McGarvey et al[7], who also reported significant depressive symptomatology in 
up to 50% of participants. The prevalence of depressive symptoms in our study was 
greater than this (91%), though again this was not measured by validated 
questionnaires, hence the severity of these reported symptoms in our respondents is 
unknown.  
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Only 53% of the survey respondents had been given a suggested diagnosis for their 
cough.   This was despite the respondents having consulted their doctor on multiple 
occasions. However, it is possible that some patients were still undergoing 
investigations for the cause of their cough and only 13% of our participants had been 
assessed in specialist cough clinics.   These factors may have contributed to the 
high prevalence of unexplained chronic cough.    Only 30% of participants felt that 
their doctor had dealt with their cough thoroughly. When a diagnosis was suggested, 
the most common cause was asthma (23%). Gastro-oesophageal reflux disease and 
upper airway cough syndrome (post-nasal drip) were also common causes, 
consistent with previous studies of cough that investigated subjects with the 
Anatomic Diagnostic Protocol as recommended by chronic cough guidelines [12, 16-
18]. As expected, some respondents reported multiple causes of cough.    
 
Our study findings suggest that there is room for improvement in the management of 
patients with chronic cough.  One approach is to increase awareness of this 
condition, and improve the implementation of chronic cough management guidelines 
in both primary and secondary care. Another approach could be to improve patient 
access to specialist cough clinics, by increasing the number of such clinics.  A key 
finding reported by participants was that their medications, including over-the-
counter medications, were ineffective. The reasons why other prescribed and over-
the counter medications were ineffective are unclear, and was beyond the scope of 
this study. Inadequate assessment of patients, dose/duration and non-compliance of 
medications and misdiagnosis could all be potential explanations[16, 17]. The 
reasons for treatment failure warrant further investigation.   
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A novel internet-based survey was used in this study to investigate the impact of 
chronic cough.   This method was simple to set up, low-cost and one that provided 
data output in an electronic format that was ready to analyse. It also facilitated the 
recruitment of participants from across Europe. The use of the internet did not inhibit 
elderly participants; the age range of our study was 18-87 years. Few surveys have 
specifically assessed the impact of chronic cough in detail. Everett et al[19] surveyed 
373 subjects with chronic cough in the community based in the UK that responded 
initially to a radio broadcast. Everett et al[19] also found that chronic cough was 
associated with a significant adverse impact on physical, psychological and social 
wellbeing of subjects. The strength of our study in contrast to Everett et al[19] was a 
larger sample size of participants with chronic cough, recruitment from 29 European 
countries and the additional capture of qualitative data (for example, participants’ 
views on information and support for cough). Fujimara et al[20] surveyed 232 
participants with chronic cough registered with a research company via e-mail. The 
recruitment of volunteers from a research company database is likely to have 
introduced a selection bias.  Seventy-four percent of participants were male, which is 
in sharp contrast to most studies of chronic cough, which report a female 
predominance. Forty-four per cent of participants had not consulted their doctor 
regarding their cough, and 75% were satisfied with over-the-counter cough 
medications.  This reflects the high number of participants with acute and sub-acute 
cough in their study. Cough, however, was associated with significant psycho-social 
impact on the subject, and females were more affected than males.   Ford et al[2] 
identified 481 participants with chronic cough in a survey of a community based in 
Yorkshire, UK. The cough was considered severe in approximately half of these 
subjects based on the disruption to activities of daily living. However, this study did 
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not report the psychosocial impact, access to specialist care or treatments used for 
cough.   Adams et al[21] identified 611 participants with chronic cough in a survey of 
a community based in Adelaide, Australia. Chronic dry cough was more common in 
participants who were male, current smokers and elderly. Cough was associated 
with significant psychological morbidity and impairment in health-related QoL, but 
this study also did not investigate the access to specialist care, treatments and 
information/support for participants. 
There are a number of limitations with this study.   Validated health-related QoL, 
activity or depression questionnaires were not used.  We used a small selection of 
questions derived from literature review of health-related QoL literature and multi-
disciplinary discussion.  This was to keep the survey brief, and therefore encourage 
completion by participants.   A significant number of respondents were excluded as 
they did not answer any of the cough-related questions. This may have been 
minimised by using a shorter questionnaire. The diagnoses and medications were 
not verified by checking medical records, as this was not feasible in this study.   The 
use of the internet to recruit participants seeking medical advice may have led to 
bias, although the wide age range of our participants and a clinical phenotype 
consistent with previous studies of chronic cough suggests that this bias may not 
have been as much as expected[10-13]. Studies of the general population, perhaps 
by telephone, would minimise selection bias but are likely to be costly and 
unfeasible. The recruitment of participants is likely to have been greater if we had 
used a commercial Google search strategy, for example a featured advertisement, 
rather than the Google AdWords account. The use of other search engines and 
strategies may have increased recruitment of subjects.  Our data does however 
suggest that the internet has the potential to recruit a large number of participants for 
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survey-based research. Our survey focused on exploring the impact of chronic 
cough however acute cough is also known to cause a significant impact on quality of 
life .[22] Future studies might explore usefully the impact of acute cough across 
Europe and serve to allow comparison with the findings of this present study. 
In conclusion, chronic cough was associated with a significant impact on their daily 
activities and health-related QoL in this European study.   Cough was undiagnosed 
in 47% of respondents.  The majority of respondents said that they would like further 
information, support and access to specialist cough clinics.    This suggests that 
much more work needs to be done to promote awareness of this condition, 
implement clinical guidelines and improve access to specialist care.    This is best 
achieved in collaboration with patient and healthcare professional societies, such as 
the ELF and the ERS.  
  
20 
 
Acknowledgements 
We would like to thank our colleagues at the ERS Chronic Cough Taskforce  for their 
valuable feedback during the development of the survey, ERS Chronic Taskforce 
members: Maria Belvisi, Kristina Bieksiene, Kian Fan Chung, Peter Dicpingaitis, 
Robert W. Dal Negro, Ahmad Kantar, Lorcan P. McGarvey, Eva Millqvist, 
Raimundas Sakalauskas, Jaclyn A. Smith. We also would like to thank all the 
respondents to the survey. 
Funding 
This study was unfunded.  
Conflict of Interest 
Authors SC, RG, AD, CB, SM, PP, SB declare that they have no conflict of interest. 
Author AP has received research grants from National Institute of Health Research 
and Pneumacare, he also received educational support from Allergan Limited, 
Biometrics Limited and GlaxoSmithKline. Author AM has received research grants 
from Boehringer Ingelheim, Cheisi Pharma, Novartis Pharmaceuticals, Orion Pharma 
UK, Procter & Gamble Health Sciences, Pfizer, Pharmaxis, Profile Pharma, MPEX 
Pharmaceuticals, PPD Development, Almirall, Seekacure, Philips Home Healthcare 
Solutions, Glenmark, Harrison Clinical Research, Janssen, Gilead, Bayer, 
Astrazeneca, Genentech, Bionoria, PRA International, GlaxoSmithKline, Allianz 
Global, Guangzhou Institute of Respiratory Disease, Cardiff Chest Federation, British 
Pharmacological Society, Italian Society of Respiratory Medicine, Drug Information 
Association, SRxA USA, Association of Inhalation Toxologists, Ardmore Healthcare 
Limited, Actelion, Hellenic Society of Respiratory and Occupational Chest Diseases, 
Primary Care respiratory Society UK, TREAT Education USA, National Health and 
Lung Institute. 
 
 
 
 
 
21 
 
References 
1. Montnémery, P., et al., Prevalence of obstructive lung diseases and 
respiratory symptoms in southern Sweden. Respir Med, 1998. 92(12): p. 
1337-45. 
2. Ford, A.C., et al., Cough in the community: a cross sectional survey and the 
relationship to gastrointestinal symptoms. Thorax, 2006. 61(11): p. 975-9. 
3. Cullinan, P., Persistent cough and sputum: prevalence and clinical 
characteristics in south east England. Respir Med, 1992. 86(2): p. 143-9. 
4. Lundbäck, B., et al., Obstructive lung disease in northern Sweden: respiratory 
symptoms assessed in a postal survey. Eur Respir J, 1991. 4(3): p. 257-66. 
5. Brignall, K., B. Jayaraman, and S.S. Birring, Quality of life and psychosocial 
aspects of cough. Lung, 2008. 186 Suppl 1: p. S55-8. 
6. Birring, S.S., et al., Development of a symptom specific health status measure 
for patients with chronic cough: Leicester Cough Questionnaire (LCQ). 
Thorax, 2003. 58(4): p. 339-43. 
7. McGarvey, L., et al., Prevalence of psychomorbidity among patients with 
chronic cough. Cough, 2006. 2(1): p. 4. 
8. Dicpinigaitis, P.V., R. Tso, and G. Banauch, PRevalence of depressive 
symptoms among patients with chronic cough*. CHEST Journal, 2006. 
130(6): p. 1839-1843. 
9. French, C.L., et al., Impact of chronic cough on quality of life. Arch Intern Med, 
1998. 158(15): p. 1657-61. 
10. Birring, S.S., et al., Respiratory symptoms in patients with treated 
hypothyroidism and inflammatory bowel disease. Thorax, 2003. 58(6): p. 533-
6. 
11. Morice, A., et al., Greater worldwide preponderence of chronic cough in 
women: A manifestation of enhanced somatosensory response? European 
Respiratory Journal, in press  
12. Morice, A.H., et al., Recommendations for the management of cough in 
adults. Thorax, 2006. 61 Suppl 1: p. i1-24. 
13. Morice, A.H., Epidemiology of cough. Pulm Pharmacol Ther, 2002. 15(3): p. 
253-9. 
14. French, C.T., K.E. Fletcher, and R.S. Irwin, Gender differences in health-
related quality of life in patients complaining of chronic cough. Chest, 2004. 
125(2): p. 482-8. 
15. French, C.T., et al., Evaluation of a cough-specific quality-of-life 
questionnaire. Chest, 2002. 121(4): p. 1123-31. 
16. Irwin, R.S. and J.M. Madison, Anatomical diagnostic protocol in evaluating 
chronic cough with specific reference to gastroesophageal reflux disease. Am 
J Med, 2000. 108 Suppl 4a: p. 126S-130S. 
17. Morice, A.H., et al., The diagnosis and management of chronic cough. Eur 
Respir J, 2004. 24(3): p. 481-92. 
18. Irwin, R., et al., Diagnosis and management of cough executive summary: 
ACCP evidence-based clinical practice guidelines. Chest, 2006. 129(1 Suppl): 
p. 1S - 23S. 
19. Everett, C.F., et al., Chronic persistent cough in the community: a 
questionnaire survey. Cough, 2007. 3: p. 5. 
22 
 
20. Fujimura, M., Frequency of persistent cough and trends in seeking medical 
care and treatment-results of an internet survey. Allergol Int, 2012. 61(4): p. 
573-81. 
21. Adams, R.J., et al., Associations of physical and mental health problems with 
chronic cough in a representative population cohort. Cough, 2009. 5: p. 10. 
22. Yousaf, N., et al., The assessment of quality of life in acute cough with the 
Leicester Cough Questionnaire (LCQ-acute). Cough, 2011. 7(1): p. 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
 
 Online Appendix A: Chronic Cough Survey 
1. How long have you had your cough? 
(<3 weeks, 3-8 weeks, 2-6 months, 6-12 months, 1-2 years, 2-5 years, 5-10 
years, 10+ years) 
 
2. What was the reason(s) for first visiting your doctor for your cough?* 
 
3. How many times have you seen your doctor regarding your cough? 
(0, 1, 2, 3, 4, 5+ times) 
 
4. When did you last see you doctor regarding your cough? 
(1 week ago, 1 month, 1-2 months, 2-6 months, 6-12 months, 1-2 years, 2-5 
years, 5+ years) 
 
5. Does your cough stop you from doing the things you would like to do? 
(Frequently, sometimes, never) 
 
6. Do you feel fed-up or depressed because of your cough? 
(Yes, sometimes, never) 
 
7. Does your cough disturb or worry your partner, family or friends? 
(Yes, sometimes, never) 
 
8. Does your cough affect your quality of life? 
(Severely, moderately, a little, not at all) 
 
Question 9.Has a diagnosis for your cough been given? 
(Yes/No) 
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10. If you received a diagnosis for your cough, what was it? 
 
11. Do you feel your doctor/specialist has dealt with your cough thoroughly? 
(Yes/no) 
 
12. Have you ever attended a specialist Cough Clinic? 
(Yes/no) 
 
13. Would you consider attending a specialist Cough Clinic if available to you? 
(Yes/no) 
 
14. Do you currently smoke? 
(Yes/no) 
 
15. Have the treatment(s) for your cough worked? 
 (Yes, a little, no) 
 
16. Please tell us what, if anything, has worked?* 
 
17. Have you found over the counter pharmacy (non-prescription) cough 
suppressant medications effective? 
 (Yes, a little, no) 
18 Would you like more information on chronic cough to be available? 
 (Yes/no) 
19. If yes, what further information would you like?* 
20. What other support do you think would be beneficial?* 
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21. Would you like to receive further information about the ELF/ERS chronic cough 
taskforce and patient involvement? 
(Yes, no) 
Demographics  
Age 
Country of Residence 
Gender 
Ethnicity 
(White Caucasian, Black Caribbean, Black African, East Asian, South Asian, Mixed, 
Other) 
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Online Appendix B: Reasons for why respondents initially consulted their 
doctor about their cough  
        Themes                                       Categories 
 
 
 
 
1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Persistent cough 
Frequency of cough 
Severity of cough 
Worsening cough 
Daytime cough 
Night time cough 
Characteristics of 
cough 
(n=422) 
Pharyngitis 
General complaints of 
not feeling well 
Fever 
Sinusitis 
Laryngitis 
      Viral Infection  
(n=140) 
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Sputum 
Breathlessness 
Problems with sleep 
Pain and discomfort 
Lethargy 
Vomiting 
Physical symptoms 
associated with 
cough 
(n=380) Irritation 
Choking symptoms  
Incontinence 
Reflux symptoms 
Haemoptysis 
Chest tightness and 
wheeze 
Changes in voice 
Frustration 
Cough taking over life 
Anxiety 
 Psychological 
symptoms associated 
with cough 
(n=88) 
Worry 
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Social anxiety 
Affecting family and 
friends 
Affecting life 
Affecting enjoyment 
of life 
Affecting work 
Social symptoms 
associated with 
cough 
(n=76) 
Asthma 
Bronchitis 
COPD 
SARS 
Primary Cilary 
Dyskinesia 
Interstitial Lung 
Disease 
To consult doctor 
regarding an existing 
respiratory or other 
health condition 
(n=80) 
Cystic Fibrosis 
Bronchiectasis  
Non-respiratory pre-
existing health 
problems 
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Diagnosis 
To get rid of cough 
Treatment of cough 
For 
diagnosis/assessment 
/treatment of cough 
(n=32) 
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Online Appendix C: Quotations from participants: why they first consulted 
their doctor 
 
Characteristics of the cough 
“Because it was continuous” (Italian responder) 
“An increase in the number of coughing fits each day: between 10 and15” (day and 
night) (French responder) 
Physical symptoms associated with cough  
“I was coughing so much my chest hurt” (Spanish survey responder) 
“Breathlessness and wheezing” (Polish survey responder) 
“I couldn’t hold conversation without coughing” (English survey responder) 
Viral infection symptoms  
“Chest infection” (English survey participant) 
Psychological symptoms associated with cough  
“Because my cough was beginning to take over my life” (French survey responder) 
“Because of the distress it was causing myself and other close persons” (English 
survey responder) 
To consult a doctor about existing respiratory or other health condition  
“”Pulmonary fibrosis, COPD” (Polish survey responder) 
“Have cystic fibrosis” (English survey responder) 
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Social symptoms associated with the cough  
“The coughing interfered with my interactions with other people” (Lithuanian survey 
responder) 
“My cough was degrading my quality of life” (Bulgarian Survey responder) 
For diagnosis/assessment and treatment of the cough  
“Clarify causes” (German responder) 
“To try to get a cure” (German responder) 
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Online Appendix D 
Information and support requested by participants (Themes and quotations) 
Treatment 
“How to treat it” (English responder) 
“An effective cure” (Italian responder) 
Causes  
“Explanation of the cause” (German responder)  
“Explain the causes of the cough because I am lost” (Polish responder) 
Self-help and alternative therapies 
“I don’t know, something we could do about it on our own” (Spanish responder) 
“How to manage the coughing, things to avoid etc” (English responder) 
“Herbal alternatives when medication simply does not work” (English responder) 
General information in a variety of formats  
“Provide information on-line, with daily updates if possible” (Spanish responder) 
“All info that might help me get rid of this inconvenience” (Swedish responder) 
“Links to internet sites so that I can obtain information on my problem” (Greek 
responder) 
“Brochure for patients” (Russian Responder) 
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Better understanding, awareness and support from doctors  
“To be taken seriously by the doctors” (German responder) 
“Information for Doctors on how to treat as they don’t seem to be very aware” 
(English responder) 
Assessment 
“What specific test to get done” (Italian responder) 
“Differential diagnosis” (English responder) 
Information on access to specialist cough clinics 
“Details of specialist cough clinics” (Italian responder) 
“Referrals to specialist to be made when symptoms have persisted for an extended 
period” (English responder) 
 
 
